How Do Anabolic Substances Work? - Episode 9: Supraphysiologic Versus Physiologic

1. Physiologic and supraphysiologic do not simply mean low and high

In endocrinology, physiologic generally describes functioning within the ordinary biological range for a given organism and context. Supraphysiologic means that exposure or concentration exceeds what the body would ordinarily produce. There is no single universal number that creates a perfect boundary.

The distinction matters for testosterone because the same molecule can be an endogenous hormone, a replacement therapy when medically indicated, or an agent administered at levels that produce pharmacological effects beyond normal physiology.

2. What does physiologic mean for testosterone?

Physiologic testosterone is produced endogenously under control of the hypothalamic-pituitary-gonadal axis. Secretion is dynamic, so a blood test is only a snapshot. Age, sampling time, SHBG, gonadal status, and metabolic state affect interpretation.

Clinical guidelines recommend diagnosing testosterone deficiency from compatible symptoms and consistently confirmed low concentrations rather than from one isolated measurement. citeturn0search4turn0search6

3. What does supraphysiologic mean?

Supraphysiologic describes exposure that drives androgenic signaling beyond the relevant physiologic range. In research, such exposure can be used to study dose-response relationships. In sport, the term describes exposure intended to produce supranormal pharmacological effects rather than simply restore endocrine function.

Importantly, supraphysiologic does not mean every effect will rise indefinitely. The body has limits in receptors, enzymes, signaling pathways, and physiological reserve.

4. The body tries to defend its equilibrium

The hypothalamic-pituitary-gonadal axis operates through negative feedback. Increasing androgenic signaling reduces GnRH, LH, and FSH, which can suppress endogenous testosterone production and spermatogenesis. Exogenous exposure is therefore not simply added on top of physiology without a regulatory response.

This connects Episode 9 to the earlier episodes on LH, FSH, and the androgen receptor: the body responds both to the molecule and to the change in its hormonal environment.

5. The concentration-effect relationship is not infinitely linear

As exposure rises, some androgenic effects can rise as well, but biological curves have limits. Receptor occupancy, cofactors, enzymes, and intracellular signaling can contribute to a plateau.

The 2001 Bhasin study is important here: graded testosterone exposure in healthy young men produced concentration-related changes in fat-free mass, muscle volume, strength, and power, while different androgen-dependent processes did not all have the same dose-response relationship. citeturn0search0turn0search1

6. The physiologic range is not an effect-free zone

Physiologic testosterone is involved in maintaining muscle mass, sexual function, erythropoiesis, bone health, and many other processes. In hypogonadism, returning toward physiologic function can provide important benefits.

That is different from pushing concentrations as high as possible. Medical treatment aims to correct deficiency, not to turn normal physiology into a supranormal pharmacological state. citeturn0search3turn0search4

7. What changes when we move beyond physiology?

Some tissues receive a stronger androgenic stimulus. This can amplify fat-free mass and components of physical performance, but can also affect hematopoiesis, lipids, reproductive function, skin, prostate, and other systems depending on the substance and context.

The organism therefore does not respond with one upward arrow. Multiple systems change simultaneously, sometimes in different directions.

8. What do testosterone studies show?

In the 2001 Bhasin study, 61 eugonadal men aged 18 to 35 received graded testosterone enanthate doses after endogenous production was suppressed. Fat-free mass increased dose dependently at the higher exposure levels, while strength, power, muscle volume, hemoglobin, and IGF-I also showed relationships with testosterone concentration. citeturn0search0

This is an experimental demonstration of dose-response, not a practical use protocol. It describes what happened under controlled conditions, not what an individual should do.

9. The 1996 study and supraphysiologic exposure

Another classic Bhasin study compared testosterone with placebo in healthy men using 600 mg of testosterone enanthate weekly for 10 weeks. Testosterone exposure increased muscle size and strength. citeturn0search10

Its importance is experimental: it demonstrates that supraphysiologic exposure can produce measurable anabolic effects. It does not establish that the same exposure is safe, necessary, or appropriate for an individual.

10. The benefit curve is not the risk curve

A desired effect may rise with exposure while an adverse effect rises faster, slower, or appears at a different point on the curve. This is why pharmacology cannot be reduced to “more means more effective.”

Net biological value requires considering efficacy together with biological costs and risks.

11. Hemoglobin and hematocrit

Androgens can stimulate erythropoiesis. In testosterone studies, hemoglobin increased with exposure. During medical testosterone therapy, hematocrit is monitored because excessive increases in red-cell mass can become clinically problematic. citeturn0search0turn0search4

This is another example of a multiple-response system: the same exposure associated with muscular adaptation can also produce hematologic changes.

12. HDL and lipid metabolism

In the 2001 Bhasin study, increasing testosterone exposure was associated with lower HDL cholesterol. A change favorable for muscle therefore cannot be evaluated independently from metabolic effects.

This is a central lesson of performance pharmacology: the body does not have a single output called performance.

13. The reproductive axis responds to the external signal

Exogenous testosterone increases negative feedback on the hypothalamic-pituitary-gonadal axis. LH and FSH fall, endogenous testicular testosterone production decreases, and spermatogenesis can be impaired. This is why testosterone therapy is not recommended as a fertility-preserving strategy for men planning fertility in the near term. citeturn0search3turn0search11

With supraphysiologic exposure, suppression is therefore part of the biological response rather than a peripheral detail.

14. DHT and estradiol still matter

Testosterone can be converted to DHT through 5-alpha-reductase and to estradiol through aromatase. As exposure changes, local metabolism contributes to the final signaling profile.

A high testosterone concentration therefore does not by itself describe every androgenic and estrogenic effect. Tissue-specific metabolism and sensitivity remain important.

15. Supraphysiologic does not mean identical exposure in every tissue

Plasma concentration is important, but tissues have their own transport, metabolism, and receptor environments. One tissue may convert testosterone locally while another responds differently to the same circulating concentration.

This helps explain why one androgen can simultaneously produce muscular, cutaneous, reproductive, hematologic, and metabolic effects with different magnitudes.

16. Receptors are not the whole story

The idea that androgen receptors simply become saturated and then concentration no longer matters is too simple. Receptor occupancy, receptor density, cofactors, and downstream signaling are distinct processes.

Dose-response studies show that some effects continue to change as androgen concentration rises. The receptor is central, but the final response belongs to the whole biological system.

17. Physiologic and supraphysiologic form a continuum

There is no biological switch that instantly turns the body from physiologic to supraphysiologic. There is a continuum of exposure. As concentration rises, some effects become more evident, some approach a plateau, and others continue to change.

The terms are useful for orientation, but they should not become rigid categories that ignore pharmacokinetics and biological context.

18. Physiologic in medicine versus physiologic in sport

In hypogonadism medicine, the goal is to restore physiologic function and improve symptoms when the diagnosis is appropriate. In performance sport, discussion of androgens may involve effects that exceed what endogenous production would normally achieve.

The same molecule can therefore appear in two very different pharmacological contexts. The context changes the objective and the risk-benefit balance.

19. What happens to performance?

Strength can increase through greater muscle mass, changes in protein synthesis, neuromuscular adaptation, body-composition changes, and other systemic effects. Increased androgenic signaling can influence some of these components.

But performance is not a pure androgen biomarker. Technique, training, sleep, nutrition, leverage, fatigue, and experience remain major determinants. There is no simple mathematical conversion between testosterone concentration and kilograms lifted.

20. Chronic exposure creates a modified biological state

With prolonged exposure, the body adapts. The endocrine axis is suppressed, tissues remodel, metabolism changes, and some systems alter their activity. Chronic exposure should therefore be viewed as a modified biological state, not merely a series of independent administrations.

21. Risk can rise before symptoms appear

Hematocrit, lipid profile, blood pressure, fertility, and endocrine variables can change without immediate symptoms. The absence of symptoms is not proof that biological effects are absent.

This is why medical monitoring relies on laboratory and objective assessment rather than only on how well someone feels.

22. Closer to maximum does not automatically mean better

A response curve can reach a region where incremental gains become smaller. At the same time, some biological costs can continue to increase. Pharmacology therefore seeks a relationship between efficacy and safety, not simply the highest possible exposure.

23. A serious analysis looks at the whole organism

Body composition and strength are only two components. Depending on context, assessment may include hemoglobin and hematocrit, lipids, blood pressure, reproductive function, relevant liver markers, and other medical parameters.

There is no single test that can declare the organism “fine.” A biological picture is built from multiple pieces.

24. What medical guidelines teach us about physiologic targets

The Endocrine Society recommends testosterone therapy for men with documented deficiency and monitoring of testosterone and hematocrit. For medically indicated therapy, the target is generally a concentration in the mid-normal range rather than supraphysiologic exposure pursued for performance. citeturn0search3turn0search4

In 2026, the Society reaffirmed the importance of accurate diagnosis and individualized assessment of benefits and risks. citeturn0search6

25. A high value is not automatically a good value

A high serum concentration is only one measurement in a complex system. Timing, formulation, pharmacokinetics, protein binding, metabolism, and target tissues all matter.

A very high value may indicate exposure beyond the physiologic objective and may increase the likelihood of unwanted effects. The correct question is what the value means in context.

26. How Episode 9 connects to Episode 8

Episode 8 explained biological dose and dose-response. Episode 9 places that curve into physiological context: what happens when androgenic signaling moves from physiologic toward supraphysiologic levels.

The chain is now clear: molecule → pharmacokinetics → exposure → receptor and metabolites → tissue response → adaptation → observable effect. None of these steps is perfectly linear.

27. What should a strongman remember?

Physiologic means functioning within the ordinary biological range. Supraphysiologic means exposure beyond that range. The difference is a change in the endocrine and pharmacological environment, not merely a larger number.

Supraphysiologic exposure can amplify muscle mass and strength, but can simultaneously alter erythropoiesis, lipids, fertility, and other systems. Effects do not all rise at the same rate, and a performance benefit does not erase biological cost.

28. Conclusion: supraphysiologic is a change of state

In physiology, testosterone is part of an endocrine system regulated by feedback. When exposure rises beyond physiologic levels, the organism does not simply receive more of the same signal. It enters a different biological state in which some effects are amplified, some plateau, and some costs may become more important.

Controlled studies show that increased androgen exposure can raise muscle mass, strength, and power, but they also show that other systems respond at the same time. The central lesson remains: the body is a dynamic system with feedback, limits, adaptation, and biological costs. citeturn0search0turn0search10

Selected sources

Bhasin S et al. Testosterone dose-response relationships in healthy young men. American Journal of Physiology-Endocrinology and Metabolism. 2001;281:E1172-E1181. PMID: 11701431.

Bhasin S et al. The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men. New England Journal of Medicine. 1996;335:1-7. PMID: 8637535.

Bhasin S et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology & Metabolism. 2018;103:1715-1744.

Endocrine Society. Statement on Testosterone Replacement Therapy. 2026.